The use of deuterium-labeled cortisol for in vivo evaluation of renal 11β-HSD activity in man: Urinary excretion of cortisol, cortisone and their A-ring reduced metabolites

Steroids

Volumn 65, Issue 2, 2000, Pages 89-97

  Kasuya, Yasuji ^a   Shibasaki, Hiromi ^a   Furuta, Takashi ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Cortisol; Cortisone; Deutrium label; GC MS; Tetrahydrometabolites

Indexed keywords

11 HYDROXYCORTICOSTEROID; CORTISONE; DEUTERIUM; HYDROCORTISONE; STEROID REDUCTASE;

ADULT; ARTICLE; GAS CHROMATOGRAPHY; HORMONE METABOLISM; HUMAN; HUMAN EXPERIMENT; ISOTOPE LABELING; MALE; MASS SPECTROMETRY; NORMAL HUMAN; STEROID METABOLISM; URINARY EXCRETION;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ADULT; CORTISONE; DEUTERIUM; HUMANS; HYDROCORTISONE; HYDROXYSTEROID DEHYDROGENASES; KIDNEY; MALE; MASS SPECTROMETRY; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE; TIME FACTORS;

EID: 0033988654     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(99)00086-0     Document Type: Article

References (36)

1. Walker B.R., Campbell J.C., Fraser R., Stewart P.M., Edwards C.R.W. Mineralocorticoid excess and inhibition of 11β-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clin Endocrinol. 37:1992;483-492.
2. Frey F.J., Escher G., Frey B.M. Pharmacology of 11β-hydroxysteroid dehydrogenase. Steroids. 59:1994;74-79.
3. Lakshmi V., Monder C. Purification and characterization of the corticosteroid 11β-dehydrogenase component of the rat liver 11β-hydroxysteroid dehydrogenase complex. Endocrinology. 123:1988;2390-2398.
4. Agarwal A.K., Monder C., Eckstein B., White P.C. Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase. J Biol Chem. 264:1989;18939-18943.
5. Tannin G.M., Agarwal A.K., Monder C., New M.I., White P.C. The human gene for 11β-hydroxysteroid dehydrogenase. J Biol Chem. 266:1991;16653-16658.
6. +-dependent isoform of 11β-hydroxysteroid dehydrogenase. Endocrinology. 131:1992;970-972.
7. Rusai E., Náray-Fejes-Tóth A. A new isoform of 11β-hydroxysteroid dehydrogenase in aldosterone target tissues. J Biol Chem. 268:1993;10717-10720.
8. Albiston A.L., Obeyesekere V.R., Smith R.E., Krozowski Z.S. Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol. 105:1994;R11-R17.
9. Stewart P.M., Murry B.A., Mason J.I. Human kidney 11β-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differ from the cloned type 1 isoform. J Clin Endocrinol Metab. 79:1994;480-484.
10. Whorwood CB, Mason JI, Ricketts ML, Howie AJ. Detection of human 11β-hydroxysteroid dehydrogenase isoforms using riverse-transcriptase-polymerase chain reaction (PCR) and localization of the type 2 isoform to renal collecting ducts. Mol Cell Endocrinol 1995;110:R71-R12.
11. Hellman L., Nakada F., Zumoff B., Fukushima D., Bradlow H.L., Gallagher T.F. Renal capture and oxidation of cortisol in man. J Clin Endocrinol Metab. 33:1971;52-62.
12. Whitworth J.A., Stewart P.M., Burt D., Atherden S.M., Edwards C.R.W. The kidney is the major site of cortisone production in man. Clin Endocrinol. 31:1989;355-361.
13. Krozowski Z.S., Funder J.W. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci USA. 80:1983;6056-6060.
14. Arriza J.L., Weinberger C., Cerelli G., et al. Cloning of human mineralocorticoid receptor complementary DNA structural and functional kinship with the glucocorticoid receptor . Science. 237:1987;268-275.
15. Edwards C.R.W., Stewart P.M., Burt D., Brett L., McIntyre M.A., Sutanto W.S., DEKloet E.R., Monder C. Localisation of 11β-hydroxysteroid dehydrogenase tissue specific protector of the mineralocorticoid receptor . Lancet ii. 1988;986-989.
16. Funder J.W., Pearce P.T., Smith R., Smith A.I. Mineralocorticoid action target tissue specificity is enzyme, not receptor, mediated . Science. 242:1988;583-585.
17. Ulick S., Levine L.S., Gunczler P., et al. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab. 49:1979;757-764.
18. Stewart P.M., Corrie J.E.T., Shackleton C.H.L., Edwards C.R.W. Syndrome of apparent mineralocorticoid excess a defect in the cortisol-cortisone shuttle . J Clin Invest. 82:1988;340-349.
19. Wilson R.C., Krozowski Z.S., Li K., et al. A mutation in the HSD11β2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab. 80:1995;2263-2266.
20. Mune T., Rogerson F.M., Nikkila H., Agarwal A.K., White P.C. Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase. Nature Genetics. 10:1995;394-399.
21. Stewart P.M., Krozowski Z.S., Gupta A., Milford D.W., Howie A.J., Sheppard M.C., Whorwood C.B. Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11β-hydroxysteroid dehydrogenase type 2 gene. Lancet. 347:1996;88-91.
22. Funder J.W. Apparent mineralocorticoid excess. Endocrinol Metab Clin North Am. 24:1995;613-621.
23. Mantero F., Palermo M., Petrelli M.D., Tedde R., Stewart P.M., Shackleton C.H.L. Apparent mineralocorticoid excess type I and type II . Steroids. 61:1966;193-196.
24. Ulick S., Tedde R., Wang J.Z. Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab. 74:1992;593-599.
25. Shackleton C.H.L. Mass spectrometry in the diagnosis of steroid-related disorders and hypertension research. J Steroid Biochem Mol Biol. 45:1993;127-140.
26. Palermo M., Shackleton C.H.L., Mantero F., Stewart P.M. Urinary free cortisone and the assessment of 11β-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol. 45:1996;605-611.
27. Best R., Walker B.R. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11β-hydroxysteroid dehydrogenase in vivo. Clin Endocrinol. 47:1997;231-236.
28. Minagawa K., Furuta T., Kasuya Y., Fujino A., Avery M.A., Tanabe M. Total synthesis of cortisol application to selective deuteriation at C-1 and C-19 . J Chem Soc Perkin Trans I. 1988;587-591.
29. Shibasaki H., Furuta T., Kasuya Y. Stereochemical aspects in the enantioselective synthesis of cortisone by the indan synthon method. Steroids. 57:1992;325-327.
30. Furuta T., Namekawa T., Shibasaki H., Kasuya Y. Simultaneous determination of tetrahydrocortisol and tetrahydrocortisone in human plasma and urine by stable isotope dilution mass spectrometry. J Chromatog B. 706:1998;181-190.
31. Kasuya Y., Iwano M., Shibasaki H., Furuta T. Pharmacokinetic studies of cortisol after oral administration of deuterium-labeled cortisol to a normal human subject. J Mass Spectrom Rapid Commun Mass Spectrom. 1995;S29-S34.
32. Kasuya Y., Ishimaru H., Shibasaki H., Furuta T. Stable isotope methodology for kinetic studies of interconversion of cortisol and cortisone in a human subject. Steroids. 63:1998;122-129.
33. Bush I.E., Mahesh V. Metabolism of 11-oxygenated steroids influence of the A/B ring junction on the reduction of 11-oxo groups . Biochem J. 71:1959;705-717.
34. Hellman L., Bradlow H.L., Zumoff B., Gallagher T.F. The influence of thyroid hormone on hydrocortisone production and metabolism. J Clin Endocrinol Metab. 21:1961;1231-1247.
35. Zumoff B., Bradlow H.L., Cassouto J., Gallagher T.F., Hellman L. Reversible Reproduction of the abnormal cortisol metabolite pattern of cirrhosis by administration of norethandrolone. J Clin Endocrinol Metab. 28:1968;92-99.
36. Gold N.I., Crigler J.F. Suggested in vivo irreversible metabolism of labeled cortisol during distribution effects on kinetic measurements and role of modes and site of administration . J Clin Endocrinol Metab. 34:1972;1025-1038.